Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 21, 2012
Grant Date -
Aug 27, 2009
app pub date -
Oct 27, 2005
filing date -
Oct 29, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Antisense oligonucleotides for treating and/or preventing at least one of asthma, allergy, hypereosinophilia, general inflammation and cancer are provided. The oligonucleotides are directed against nucleic acid sequences coding for a receptor selected from the group consisting of a CCR3 receptor and a common sub-unit of IL-3, IL-5 and GM-CSF receptors.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully